Literature DB >> 26615029

Anti-carbamylated protein antibodies in patients with ageing associated inflammatory chronic disorders.

Marcos López-Hoyos1, Lorena Álvarez-Rodríguez2, Michael Mahler3, Silvia Torices2, Jaime Calvo-Alén4, Ignacio Villa4, Andrea Seaman3, Alvin Yee3, Victor Martínez-Taboada2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26615029     DOI： 10.1093/rheumatology/kev391

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

2.  [Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus].

Authors:  Y N Li; X H Xiang; J Zhao; Y Li; F Sun; H Y Wang; R L Jia; F L Hu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

3.  Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.

Authors:  Michael Ziegelasch; Myrthe A M van Delft; Philip Wallin; Thomas Skogh; César Magro-Checa; Gerda M Steup-Beekman; Leendert A Trouw; Alf Kastbom; Christopher Sjöwall
Journal:  Arthritis Res Ther       Date:  2016-12-03       Impact factor: 5.156

4.  Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis.

Authors:  Hui-Chun Yu; Pei-Hsuan Lai; Ning-Sheng Lai; Hsien-Bin Huang; Malcolm Koo; Ming-Chi Lu
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.